NCT04388202View on ClinicalTrials.gov

Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 15, 2020

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions
Major Depressive Disorder
Interventions
DRUG

Sertraline

FDA approved antidepressant

DRUG

Escitalopram

FDA approved antidepressant

Sponsors

Lead Sponsor

Alto Neuroscience
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Alto Neuroscience

INDUSTRY